Chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder and patients
respond differently to treatment. Blood eosinophils are a potential biomarker to stratify …

The management of chronic obstructive pulmonary disease (COPD) is fundamentally still
heavily dependent on the use of bronchodilators and corticosteroids. Therefore, there is a …

Inhaled corticosteroids (ICS) are the mainstay of treatment for asthma, but their role in
chronic obstructive pulmonary disease (COPD) is debated. Recent randomised controlled …

La candidiasis o candidosis oral es la enfermedad infecciosa ocasionada por el crecimiento
de las colonias de Cándida y la penetración de las mismas en los tejidos orales cuando las …

Chronic obstructive pulmonary disease (COPD) is a chronic, complex, and heterogeneous
condition with significant mortality, morbidity, and socioeconomic burden. Given the …

Introduction: A growing body of evidence indicates that prevalence of chronic obstructive
pulmonary disease (COPD) has been increasing more rapidly among women compared to …

Introduction: Roflumilast is the only phosphodiesterase 4 inhibitor approved for the treatment
of COPD patients with chronic cough and sputum, and a history of exacerbations, but the …

Diabetes occurs more often in individuals with COPD than in the general population,
however there are still many issues that need to be clarified about this association. The …

Background COPD is an inflammatory airway disease characterised by progressive airflow
limitation and air trapping, leading to lung hyperinflation and exercise limitation. Acute …

Background: Blood eosinophils may predict response to inhaled corticosteroids (ICS) in
chronic obstructive pulmonary disease (COPD) where ICS is recommended in patients at …